[Fever and thin-walled cavitary lung lesions].
Ramos
Antonio
A
Servicio de Medicina Interna III, Hospital Universitario Puerta de Hierro, Universidad Autónoma de Madrid, Madrid, España. antrammar@yahoo.es
Daza
Rosa
R
Alvarez-Espejo
Teresa
T
Guzmán
María Fernanda
MF
D000328:Adult; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000008:administration & dosage / Q000627:therapeutic use; D005334:Fever / Q000209:etiology*; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D009165:Mycobacterium Infections, Nontuberculous / Q000150:complications / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000382:microbiology; D019909:Mycobacterium kansasii / Q000187:drug effects / Q000302:isolation & purification*; D011718:Pyrazinamide / Q000008:administration & dosage / Q000627:therapeutic use; D011859:Radiography; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use; D013183:Sputum / Q000382:microbiology; D014397:Tuberculosis, Pulmonary / Q000150:complications / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000382:microbiology
D000995:Antitubercular Agents; D011718:Pyrazinamide; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin